Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
79.99
-10.45 (-11.55%)
At close: Dec 5, 2025, 4:00 PM EST
80.02
+0.03 (0.04%)
After-hours: Dec 5, 2025, 7:43 PM EST
Spruce Biosciences Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Spruce Biosciences stock ranges from a low of $37.5 to a high of $259. The average analyst price target of $152.17 forecasts a 90.24% increase in the stock price over the next year.
Price Target: $152.17 (+90.24%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Spruce Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 1 | 1 | 2 |
| Hold | 5 | 5 | 5 | 5 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $160 | Hold → Buy | Upgrades | $160 | +100.03% | Dec 3, 2025 |
| Citizens | Citizens | Buy Maintains $254 → $259 | Buy | Maintains | $254 → $259 | +223.79% | Nov 11, 2025 |
| JMP Securities | JMP Securities | Hold → Buy Upgrades $254 | Hold → Buy | Upgrades | $254 | +217.54% | Oct 28, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $10 → $160 | Hold | Maintains | $10 → $160 | +100.03% | Oct 21, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $113 → $38 | Hold | Maintains | $113 → $38 | -53.12% | Apr 16, 2025 |
Financial Forecast
Revenue This Year
n/a
from 4.91M
Revenue Next Year
n/a
EPS This Year
-13.59
from -96.39
EPS Next Year
-4.19
from -13.59
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.96 | 20.96 | |
| Avg | -13.59 | -4.19 | |
| Low | -23.36 | -27.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.